Carregant...
Systemic Perturbation of the ERK Signaling Pathway by the Proteasome Inhibitor, MG132
Inhibition of the ubiquitin-proteasome protein degradation pathway has been identified as a viable strategy for anti-tumor therapy based on its broad effects on cell proliferation. By the same token, the variety of elicited effects confounds the interpretation of cell-based experiments using proteas...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3511445/ https://ncbi.nlm.nih.gov/pubmed/23226437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0050975 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|